Meridian Bioscience Inc. (VIVO) Financial Statements (2024 and earlier)

Company Profile

Business Address 3471 RIVER HILLS DR
CINCINNATI, OH 45244
State of Incorp. OH
Fiscal Year End September 30
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49,77153,51462,39759,76357,07247,226
Cash and cash equivalents49,77153,51462,39759,76357,07247,226
Receivables53,56838,51235,60832,33629,10627,102
Inventory, net of allowances, customer advances and progress billings76,84261,26439,61741,99341,49345,057
Inventory76,84261,26439,61741,99341,49345,057
Other undisclosed current assets12,6268,9007,1394,9616,2047,406
Total current assets:192,807162,190144,761139,053133,875126,791
Noncurrent Assets
Property, plant and equipment43,21431,12030,56729,99530,51030,450
Intangible assets, net (including goodwill)     81,63091,837
Goodwill     54,92661,982
Intangible assets, net (excluding goodwill)     26,70429,855
Derivative instruments and hedges     815 
Restricted cash and investments     1,0001,000
Other noncurrent assets213,701211,951150,15082,329421353
Other undisclosed noncurrent assets     1,5261,392
Total noncurrent assets:256,915243,071180,717112,324115,902125,032
TOTAL ASSETS:449,722405,261325,478251,377249,777251,823
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities39,42937,51620,91418,92316,29218,821
Taxes payable3,8483,5241,9803351,2481,482
Employee-related liabilities16,85316,6617,9387,2634,5367,106
Accounts payable11,70111,9697,2386,2607,7197,627
Accrued liabilities7,0275,3623,7585,0652,7892,606
Debt    5,2504,5003,750
Estimated litigation liability      
Business combination, contingent consideration, liability  12,619  2,095 
Other undisclosed current liabilities7,7282,389    
Total current liabilities:47,15752,52420,91424,17322,88722,571
Noncurrent Liabilities
Long-term debt and lease obligation63,93273,50275,82444,93050,14754,610
Long-term debt, excluding current maturities60,00068,82475,82444,93050,14754,610
Liabilities, other than long-term debt2,90220,42937,0346,0746,3707,493
Accounts payable and accrued liabilities469549549441  
Deferred tax liabilities, net3,7694,4552,753
Deferred income tax liabilities1,0553,8042,366
Liability, pension and other postretirement and postemployment benefits  1,8401,9171,8641,6801,628
Other liabilities175233    
Operating lease, liability3,9324,678 
Business combination, contingent consideration, liability 1,00013,29032,202 2352,383
Derivative instruments and hedges, liabilities 203713   729
Other undisclosed noncurrent liabilities7,42911,177739782788677
Total noncurrent liabilities:74,263105,108113,59751,78657,30562,780
Total liabilities:121,420157,632134,51175,95980,19285,351
Equity
Equity, attributable to parent328,302247,629190,967175,418169,585166,472
Treasury stock, value      
Additional paid in capital147,403140,195132,834129,193125,608122,356
Accumulated other comprehensive income (loss)198(1,860)(4,975)(3,377)(2,946)(5,516)
Retained earnings180,701109,29463,10849,60246,92349,632
Total equity:328,302247,629190,967175,418169,585166,472
TOTAL LIABILITIES AND EQUITY:449,722405,261325,478251,377249,777251,823

Income Statement (P&L) ($ in thousands)

9/30/2022
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Revenues317,896253,667201,014213,571200,771196,082
Revenue, net200,771196,082
Cost of revenue
(Cost of Goods and Services Sold)
(116,748)(97,419)(82,689)(83,110)(75,938)(68,295)
Gross profit:201,148156,248118,325130,461124,833127,787
Operating expenses(108,114)(94,924)(85,626)(98,877)(87,451)(76,409)
Operating income:93,03461,32432,69931,58437,38251,378
Nonoperating expense(2,583)(2,031)(1,142)(1,204)(953)(734)
Investment income, nonoperating 14268141817167
Other nonoperating income (expense)(1,705)459122(102)51896
Interest and debt expense(1,878)(2,632)(1,945)(1,520)(1,642)(897)
Income from continuing operations before equity method investments, income taxes:88,57356,66129,61228,86034,78749,747
Other undisclosed income from continuing operations before income taxes1,8782,6321,9451,5201,642897
Income from continuing operations before income taxes:90,45159,29331,55730,38036,42950,644
Income tax expense(19,044)(13,107)(7,175)(6,531)(14,872)(18,415)
Income from continuing operations:71,40746,18624,38223,84921,55732,229
Income before gain (loss) on sale of properties:71,40746,18624,38223,84921,55732,229
Net income available to common stockholders, diluted:71,40746,18624,38223,84921,55732,229

Comprehensive Income ($ in thousands)

9/30/2022
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Net income:71,40746,18624,38223,84921,55732,229
Comprehensive income:71,40746,18624,38223,84921,55732,229
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,0583,115(1,598)(431)2,570(3,186)
Comprehensive income, net of tax, attributable to parent:73,46549,30122,78423,41824,12729,043

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: